FDA Announces Joint Meeting of Advisory Committees for Nonprescription Drugs and Anesthetic Drugs

Summary

The FDA is hosting a joint meeting of the Nonprescription Drugs Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee to provide advice on regulatory issues, with a public docket for comments.